3D Printed Drugs Market | Aprecia Pharmaceuticals, GlaxoSmithKline Plc, Hewlett Packard Caribe, BV, LLC, 3D Printer Drug Machine, FabRx Ltd.

A new market research report on the Global 3D Printed Drugs market has introduced by KD Market Insights. The report is dedicated to in-depth industry analysis of the global 3D Printed Drugs market. The Global 3D Printed Drugs analysis is broken down on different segmentation levels including Market BY SCENARIO.

Spritam is the only 3D printed drug which has received FDA approval. This drug was first available in the market in 2016, and can be used to treat epilepsy. The potential market for other 3D printed drugs (moderate growth scenario) is estimated to be $278 million in 2020, and would reach $522 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030. 3D printed drugs are developed by 3D printing technology to treat patients and children affected with dysphagia. These drugs are highly porous in nature and disintegrate rapidly, which eliminate the need to directly swallow the intact high-dose medicine.

Get Report Sample Copy @ https://www.kdmarketinsights.com/sample/5125

The growth of the 3D printed drugs market is driven by upsurge in demand of instantaneous soluble drugs, rise in geriatric population, and high adoption of 3D printing technology. In addition, rapid technological advancements, increase in awareness about the 3D printing, and improvement in healthcare infrastructure fuel the market growth. However, factors such as adverse effects related to these drugs, lack of government regulations for these drugs, and use of 3D printing to develop illegal drugs are expected to restrain the market growth. Conversely, introduction of 3D printed drugs by various key vendors in developing nations and increase in healthcare investment in emerging nations are expected to provide lucrative opportunities for the market growth in the near future.

The market is segmented on the basis of Spritam, scenario, and geography. For Spritam, market is categorized on the basis of geography into U.S. and rest of North America. On the basis of scenario, the market is categorized into low growth scenario, moderate growth scenario, and rapid growth scenario. Geographically, it is analyzed across North America (U.S. and rest of North America), Europe (UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
– The study provides an in-depth analysis of the global 3D printed drugs market with current trends and future estimations to elucidate the investment pockets.
– Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
– The report offers a quantitative analysis to assist the stakeholders to capitalize on prevailing market opportunities.
– Extensive analysis of different segments facilitates to determine various products available in the market.
– Key players are profiled and their strategies are analyzed thoroughly to predict the competitive market outlook.

SPRITAM MARKET, BY GEOGRAPHY
– U.S.
– Rest of World

OTHER DRUGS POTENTIAL MARKET, BY SCENARIO
– Low Growth Scenario
– Moderate Growth Scenario
– Rapid Growth Scenario

OTHER DRUGS POTENTIAL MARKET, BY REGION
– North America
– – U.S.
– – Rest of North America
– Europe
– – UK
– – Germany
– – France
– – Italy
– – Spain
– – Rest of Europe
– Asia-Pacific
– – Japan
– – China
– – Australia
– – Rest of Asia-Pacific
– LAMEA
– – Brazil
– – Saudi Arabia
– – Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
– Aprecia Pharmaceuticals
– GlaxoSmithKline Plc.
– Hewlett Packard Caribe, BV, LLC
– 3D Printer Drug Machine
– FabRx Ltd.

LIST OF ORGANIZATIONS PROFILED IN THE REPORT
– UCL School of Pharmacy
– University of Glasgow
– University College London
– The University of Nottingham
– National University of Singapore

LIST OF OTHER ORGANIZATIONS IN THE VALUE CHAIN (These players are not profiled in the report, but can be included on client request.)
– University of Michigan
– bo Akademi University
– University of Sheffield

Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/3d-printed-drugs-market-amr

Table of Content

CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS

CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. 3D PRINTED DRUGS: AN OVERVIEW
3.2.1. Why 3D printed drugs?
3.2.2. Indications
3.2.2.1. Dysphagia: target population
3.2.2.2. Other indications
3.2.3. What to expect?
3.2.3.1. Customized dosage forms
3.2.3.1.1. Color
3.2.3.1.2. Flavor
3.2.3.1.3. Shape
3.2.3.1.4. Personalized medications
3.2.3.2. Release of complex drugs
3.2.4. 3D drug printing technologies
3.2.4.1. Inkjet printing
3.2.4.2. Direct-write
3.2.4.3. Zip dose
3.2.4.4. Thermal inkjet (TIJ) printing
3.2.4.5. Fused deposition modelling (FDM)
3.2.4.6. Powder bed printing
3.2.4.7. Stereolithography (SLA)
3.3. MARKET DYNAMICS
3.3.1. Drivers
3.3.1.1. High demand of instantaneous soluble tablets
3.3.1.2. Increasing prevalence of dysphagia
3.3.1.3. Growing usage of 3D printing
3.3.1.4. Increasing adoption of personalized drugs
3.3.2. Restraints
3.3.2.1. 3D printing could be used to print illegal drugs
3.3.2.2. Stringent government regulations for 3D printed products
3.3.3. Opportunities
3.3.3.1. Growing healthcare infrastructure and increase in healthcare investment in emerging nations
3.3.3.2. Rising awareness about the 3D printing technology
3.3.4. Impact analysis

CHAPTER 4 SPRITAM: 3D PRINTED DRUGS MARKET
4.1. OVERVIEW
4.1.1. Key market trends
4.1.2. Growth factors and opportunities
4.2. MARKET SIZE AND FORECAST
4.3. BY GEOGRAPHY
4.3.1. U.S.
4.3.1.1. Key market trends
4.3.1.2. Growth factors and opportunities
4.3.1.3. Market size and forecast
4.3.2. Rest of World
4.3.2.1. Growth factors and opportunities
4.3.2.2. Market size and forecast

CHAPTER 5 OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY SCENARIO
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. LOW GROWTH SCENARIO
5.2.1. Market size and forecast
5.3. MODERATE GROWTH SCENARIO
5.3.1. Market size and forecast
5.4. HIGH GROWTH SCENARIO
5.4.1. Market size and forecast

CHAPTER 6 OTHER 3D PRINTED DRUGS POTENTIAL MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Rest of North America
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. UK
6.3.5. Germany
6.3.6. France
6.3.7. Italy
6.3.8. Spain
6.3.9. Rest of Europe
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. Australia
6.4.7. Rest of Asia-Pacific
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. Saudi Arabia
6.5.6. Rest of LAMEA

CHAPTER 7 COMPANY PROFILES
7.1. APRECIA PHARMACEUTICALS COMPANY
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Key strategic moves and developments
7.2. FABRX LTD.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.3. GLAXOSMITHKLINE PLC
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Business performance

Continue @...

Check for Discount @ https://www.kdmarketinsights.com/discount/5125

Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com
https://prnewslight.blogspot.com/
https://newstrendmirror.blogspot.com/

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

This release was published on openPR.